Recycled and reused: scientists develop a library to help teach old drugs new tricks.

Gene is in charge of seed train duty! But the reality doesn’t quite live up to his expectations…

When it comes to the crunch – the swab test – planning and preparation are the key to the best performance.

No-deal Brexit poses unique challenges for the development and advanced therapy sectors, not least tight timelines and a limited ability to stockpile.

The Chinese pharmaceutical market is already more advanced than many in the West imagine – and it only looks set to go in one direction.

With so much technology at our disposal, it’s time to get smart in formulation by adopting in silico approaches.

Gene therapy deals, clinical trials transparency and sartan medicine reviews… what’s new for pharma in business?

What did the partial government shutdown mean for the US pharma industry?

The Medicine Maker speaks with Michel Legarde, President of Pharmaceutical Services, Patheon, part of Thermo Fisher Scientific.

The Medicine Maker speaks with Nick Shackley, VP of Johnson Matthey